ArticlePlant biotechnology journal2026
Systemic Delivery of Functional Proteins Into Plants Using an Engineered Membrane Translocation Domain.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Plant Immune Elicitors for Postharvest Fruit Preservation: Multifunctional Benefits, Emerging Secreted Protein Elicitors, and Future Perspectives.International journal of molecular sciences · 2026Review
- Intracellular Delivery of Peptides and Proteins with an Engineered Membrane Translocation Domain.ACS chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Protein-based biopesticides and biostimulants are critical for the future of sustainable agriculture, yet their utility is severely limited by inefficient delivery into plant cells. Traditional cell-penetrating peptides enable protein uptake but lack the efficiency, systemic activity and scalability required for crop production. Here, we present a potential general solution using a novel engineered membrane translocation domain, MTD4, to enable robust, systemic protein delivery into crops and it is suitable for large-scale application. We first demonstrate that MTD4 enables rapid foliar delivery of a model protein (SEP) and, importantly, facilitates its systemic translocation from lower to upper leaves and from roots to shoots, a key requirement for whole-plant protection. To prove the platform's utility, we fused MTD4 to the harpin protein HrpZ, a known defence elicitor. MTD4-HrpZ delivered into tobacco and tomato plants triggered a potent hypersensitive response and systemic acquired resistance, resulting in significant reductions in disease severity from bacterial and fungal pathogens. Remarkably, the MTD4-HrpZ fusion protein was over five times more effective than HrpZ alone, highlighting MTD4's capacity to dramatically enhance protein efficacy. This work introduces MTD4 as a transformative tool for overcoming protein delivery barriers in plants, paving the way for a new generation of high-potency biotherapeutics that can advance sustainable crop protection and reduce dependence on chemical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.